Resultados de la búsqueda 71-80 of 11895 for Opioid toxicity

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The primary purpose of this study is to collect Biospecimens from patients who developed chemotherapy related cardiac toxicity (CRCT) and patients who are ...

2. Radiología - Ensayos clínicos - Mayo Clinic

   * Is \[Ac225\]RTX-2358 tolerable or does it cause toxicities (medical problems) in patients. ... A Study to Assess Opioid-Induced Respiratory Depression Using ...

3. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

   ... toxicity. 2nd arm - An additional group of patients will be enrolled if they previously received FQ antibiotics. appear to be symptomatic and have a ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Primary Goal: To determine the toxicity of in-house, manufactured MUC1-activated T cells in patients with relapsed/refractory MUC1-expressing multiple ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to develop an evidenced-based guideline for pediatric opioid prescribing guideline from the emergency department for long bone ...

6. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

   ... toxicity. 2nd arm - An additional group of patients will be enrolled if they previously received FQ antibiotics. appear to be symptomatic and have a ...

7. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

   ... toxicity. 2nd arm - An additional group of patients will be enrolled if they previously received FQ antibiotics. appear to be symptomatic and have a ...

8. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

   ... toxicity. 2nd arm - An additional group of patients will be enrolled if they previously received FQ antibiotics. appear to be symptomatic and have a ...

9. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

   Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

10. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...